Suven Pharmaceuticals Limited (NSE: SUVENPHAR)
India
· Delayed Price · Currency is INR
1,116.65
-13.45 (-1.19%)
Dec 24, 2024, 3:30 PM IST
Suven Pharmaceuticals Company Description
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally.
It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies.
The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.
Suven Pharmaceuticals Limited
Country | India |
Founded | 1989 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,193 |
CEO | Sudhir Singh |
Contact Details
Address: Galaxy Towers Hyderabad, 500081 India | |
Phone | 91 40 2354 9414 |
Website | suvenpharm.com |
Stock Details
Ticker Symbol | SUVENPHAR |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE03QK01018 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Sudhir Kumar Singh Ph.D. | Chief Executive Officer |
Himanshu Agarwal | Chief Financial Officer |
Cyndrella Carvalho | Head of Investor Relations |
Kundan Kumar Jha | Company Secretary and Compliance Officer |
Gaurav Narain Bahadur | Chief Human Resources Officer |
Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju | MD and Director |
Subba Raju Komaravolu | Chief Strategy Officer |
Sunder Venkatraman | Vice President of Corporate Affairs |